Two SME IPOs open for subscription today: Anand Seamless and Himalaya Nutravedics — check key details

The SME IPO market is set for a busy start as two public issues — Anand Seamless Tubes and Himalaya Nutravedics — open for subscription today, September 22, 2026. Both issues will remain open until September 24, giving investors three days to place their bids.

The two companies are looking to raise a combined Rs 52.02 crore through their respective SME IPOs. Both issues are entirely fresh issues, with the proceeds earmarked for a mix of business expansion, working capital, debt repayment and other corporate requirements.

Read more: NSE IPO Tracker: Catch all the highlights here

Anand Seamless IPO

The Anand Seamless IPO is a fixed-price issue of Rs 25.52 crore, comprising a fresh issue of 35.44 lakh shares. The issue opens on September 22 and closes on September 24, 2026. The allotment is expected to be finalised on September 25, while the shares are proposed to be listed on the BSE SME platform on September 29, 2026.

The company has fixed the issue price at Rs 72 per share. The lot size is 1,600 shares, making the minimum retail application size 3,200 shares, or an investment of Rs 2,30,400. For HNI investors, the minimum application is 3 lots, or 4,800 shares, requiring an investment of Rs 3,45,600.

Aftertrade Broking Pvt. Ltd. is the book-running lead manager for the issue, while MUFG Intime India Pvt. Ltd. is the registrar.

A significant portion of the Anand Seamless IPO proceeds will be used to strengthen its manufacturing operations, including capacity expansion, technological upgrades, cost optimisation and support for its manufacturing facility in Mahesana, Gujarat. The company also plans to use Rs 5.73 crore to repay or prepay certain outstanding secured and unsecured borrowings, while Rs 3.70 crore is earmarked for general corporate purposes and Rs 3.13 crore towards issue expenses.

Read more: A record run! NSE IPO draws Rs 90,000 crore demand, takes subscription crown among India’s 5 largest offerings

Himalaya Nutravedics IPO

The Himalaya Nutravedics IPO is a book-built issue of Rs 26.50 crore, comprising an entirely fresh issue of 25 lakh shares. The IPO also opens for subscription on September 22 and closes on September 24, 2026. The allotment is expected to be completed on September 25, with a tentative listing on the BSE SME platform on September 29.

The company has fixed a price band of Rs 100 to Rs 106 per share. The lot size is 1,200 shares.

For retail investors, the minimum application is 2,400 shares, requiring an investment of Rs 2,54,400 at the upper end of the price band. The minimum HNI application is 3 lots, or 3,600 shares, translating into an investment of Rs 3,81,600 at the upper price of the band.

Nirbhay Capital Services Pvt. Ltd. is the book-running lead manager, while KFin Technologies Ltd. is the registrar to the issue.

IPO proceeds: Himalaya Nutravedics plans to use a major portion of the IPO proceeds to meet its working capital requirements, with Rs 13.75 crore earmarked for this purpose. The company will also allocate Rs 7.50 crore towards business development and digital marketing activities, while the remaining proceeds will be used for general corporate purposes.

Two SME issues, two different funding priorities

While both IPOs are entering the market on the same day and are targeting BSE SME listing, their proposed use of funds reflects different business priorities.

Anand Seamless is directing a substantial portion of its proposed proceeds towards manufacturing capacity, technology upgrades and debt reduction, whereas Himalaya Nutravedics is looking to strengthen its working capital position and business development initiatives.

With both issues open from September 22 to September 24, investors will be able to evaluate the companies on factors such as their financial performance, valuation, business prospects, use of IPO proceeds and the risks outlined in their respective offer documents before making an investment decision.

Disclaimer: The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here